https://www.selleckchem.com/pr....oducts/cefodizime-so
At the mean follow-up of 10.4 ± 2.4 months, LD at distal reference was significantly increased by 25% from baseline to follow-up in the overall population (1.88 ± 0.57 vs. 2.21 ± 0.41 mm, p less then 0.001), with a greater increase in patients with MB compared to those without (46 ± 31% vs. 17 ± 29%, p less then 0.001). Multivariable analysis indicated MB as an independent predictor of late lumen enlargement. In patients with MB on IVUS, CTO was located in more proximal segment of LAD than those without. Late lumen enlarge